Kraig Biocraft Laboratories, Inc. (KBLB.OB) Anticipates Success
Source: http://Blog.QualityStocks.net/?p=15661Posted on Thursday, July 2nd, 2009 | In Market Commentary, Small & Micro Cap
Emerging biotech company, Kraig Biocraft Laboratories, Inc. was founded by the inventor of the company’s technology, current chief executive officer, Kim Thompson. The company is a fully reporting organization and trades on the over-the-counter market under the stock symbol KBLB. As of last report, there are about 501 million common shares outstanding, with approximately 64% held by the chief executive officer.
Kraig Biocraft Laboratories’ CEO serves as the overall coordinator for the company relative to business operations and ongoing research and development. Several prominent genetic scientists have significantly developed the companies’ technologies. Additionally, the laboratory staffs of these professors are also making significant contributions to the company’s efforts.
Kraig Biocraft Laboratories, Inc. has a developed intellectual portfolio relating to the harvesting of silk from genetically modified silkworms. The company brings together preeminent researchers in a collaborative effort to produce commercially significant quantities of spider silk, one of the world’s strongest and most resilient fibers.
In order to achieve this goal, the company has aligned itself with teams from the University of Notre Dame and the University of Wyoming, two leading research universities. The project includes Dr. Malcolm Fraser of Notre Dame, a noted genetic scientist and a member of the first team of researchers to develop a transgenic silkworm, and Dr. Randy Lewis of the University of Wyoming, one of the world’s foremost authorities on spider silk. The University of Wyoming, which holds significant intellectual property rights relating to the genetic sequencing of spiders, is a meaningful equity investor in the company.
Efforts to produce the desired proteins in a transgenic silkworm have significantly accelerated over the past several months, possibly leading to a breakthrough in the laboratory by the end of this year. The perfected technology required for the project is expected to arrive a year following the breakthrough.
Let us hear your thoughts: Kraig Biocraft Laboratories, Inc. Message Board
Last 5 posts by QualityStocks
- View Systems (VSYM.OB) Up Almost 150% After Coverage by QualityStocks Newsletter - November 24th, 2009
- Consorteum Holdings, Inc. (CSRH.OB) Offers Right Source Solutions in the Payments and Transactions Industry - November 24th, 2009
- Some Options as the US Dollar Continues its Slide - November 24th, 2009
- Newport Digital Technologies (NPDT.OB) Has a Competitive Edge - November 24th, 2009
- Small Cap Voice Featured Company: DecisionPoint Systems, Inc. (DNPI.OB) - November 24th, 2009
ceo, Chief Executive Officer, current chief executive officer, Kim Thompson;, Kraig Biocraft Laboratories Inc.;, Malcolm Fraser;, Market Commentary, noted genetic scientist and a member, noted genetic scientist and a member of the first team, Notre Dame, overall coordinator, perfected technology, Randy Lewis;, Small & Micro Cap, The Macro Trader, University of Notre Dame, University of Wyoming;, Wyoming
![]() About QualityStocks (http://QualityStocks.net)
Our name, QualityStocks, emphasizes our commitment to connect subscribers with companies that have huge potential to succeed in the short and long-term future. We believe strong management and vision for the future are crucial for any company to be successful. Timing is everything and we help investors succeed by providing an objective, broad-based view of the SmallCap markets on a daily basis. Please see disclaimer on QualityStocks website: http://disclaimer.qualitystocks.net |




